Company: SNY
Filing Date: 2025-02-13
Form Type: 20-F
Source: 0001121404-25-000010
Chunk: 467

Company: Sanofi
Filing Date: 2025-02-13
Form: 20-F
Chunk 467
---
 sharing of (profits)/losses under the MonoclonalAntibody Alliance | -4,143 | -3,321 | -2,325 |
| Additional share of profit paid by Regeneron towards development costs(a)                     |    833 |    668 |    434 |
| Reimbursement to Regeneron of selling expenses incurred                                       |   -637 |   -543 |   -476 |
| Total - Monoclonal Antibody Alliance                                                          | -3,947 | -3,196 | -2,367 |
| Immuno-Oncology Alliance                                                                      |      — |      — |     16 |
| Other (mainly Zaltrap and Libtayo)                                                            |    158 |    217 |  1,120 |
| Other operating income/(expenses), net related to Regeneron                                   | -3,789 | -2,979 | -1,231 |
| of which amount presented inOther operating income(Note D.25.)                                |    166 |    227 |  1,147 |

(a) As of December 31, 2024, the commitment received by Sanofi in respect of the additional profit share payable by Regeneron towards development

costs amounted to € 1.6billion , compared with € 2.1billion as of December 31, 2023 (see Note D.21.).

Charges to provisions for litigation and environmental risks are also recorded within this line item.

D.27. Restructuring costs and similar items

Restructuring costs and similar items amounted to € 1,396 million in 2024 , € 1,030 million in 2023 and € 1,077 million in 2022 , and

were comprised of the following items:

| (€ million)                              |  2024 |  2023 | -a |  2022 | -a |
| Employee-related expenses                |   963 |   404 |    |   471 |    |
| Charges, gains or losses on assets(b)    |     4 |   273 |    |   261 |    |
| Costs related to transformation programs |   285 |   330 |    |   325 |    |
| Other                                    |   144 |    23 |    |    20 |    |
| Total                                    | 1,396 | 1,030 |    | 1